Value of first-line surgical treatment for classic Kaposi sarcoma and potential use of checkpoint inhibitors
J Dtsch Dermatol Ges
.
2020 Mar;18(3):256-262.
doi: 10.1111/ddg.14039.
Epub 2020 Feb 17.
Authors
Robin Reschke
1
,
Sonja Grunewald
1
,
Monica Schüürmann
1
,
Jan-Christoph Simon
1
,
Mirjana Ziemer
1
Affiliation
1
Department of Dermatology, Venereology and Allergology, Leipzig University Medicine, Leipzig, Germany.
PMID:
32065706
DOI:
10.1111/ddg.14039
No abstract available
Publication types
Letter
MeSH terms
Aged
Aged, 80 and over
Female
Humans
Immune Checkpoint Inhibitors / therapeutic use*
Male
Sarcoma, Kaposi / surgery*
Skin Neoplasms / surgery*
Substances
Immune Checkpoint Inhibitors